348
Views
16
CrossRef citations to date
0
Altmetric
Reviews

The role of solithromycin in the management of bacterial community-acquired pneumonia

&
Pages 311-324 | Received 04 Nov 2015, Accepted 04 Jan 2016, Published online: 05 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bela Kocsis & Dora Szabo. (2017) New treatment options for lower respiratory tract infections. Expert Opinion on Pharmacotherapy 18:13, pages 1345-1355.
Read now
Diego Viasus, Oscar Ramos, Leidy Ramos, Antonella F. Simonetti & Jordi Carratalà. (2017) Solithromycin for the treatment of community-acquired bacterial pneumonia. Expert Review of Respiratory Medicine 11:1, pages 5-12.
Read now

Articles from other publishers (14)

Longlong Jin, Xiaoxi Zhang, Zhigang Luo, Xianfu Wu & Zhehui Zhao. (2023) Synthesis and antibacterial activity of novel 2‑fluoro ketolide antibiotics with 11,12‑quinoylalkyl side chains. Bioorganic & Medicinal Chemistry Letters 80, pages 129115.
Crossref
Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati & Pooja Chawla. (2022) Discovery and Development of Antibacterial Agents: Fortuitous and Designed. Mini-Reviews in Medicinal Chemistry 22:7, pages 984-1029.
Crossref
Junlin Wen, Feng Chen, Mengxin Zhao & Xiaoping Wang. (2019) Solithromycin monotherapy for treatment of community‐acquired bacterial pneumonia: A meta‐analysis of randomised controlled trials. International Journal of Clinical Practice 73:5, pages e13333.
Crossref
David A. Lewis. (2019) New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance. Sexual Health 16:5, pages 449.
Crossref
Alexandra M. Mancuso, Mona A. Gandhi & Judianne Slish. (2017) Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea. Journal of Pharmacy Practice 31:2, pages 195-201.
Crossref
Daniel Evans, Samuel Yalkowsky, Sara Wu, David Pereira & Prabha Fernandes. (2018) Overcoming the Challenges of Low Drug Solubility in the Intravenous Formulation of Solithromycin. Journal of Pharmaceutical Sciences 107:1, pages 412-418.
Crossref
Ronald Anderson & Charles Feldman. (2017) Pneumolysin as a potential therapeutic target in severe pneumococcal disease. Journal of Infection 74:6, pages 527-544.
Crossref
Muhammad-Hariri Mustafa, Shaunak Khandekar, Michael M. Tunney, J. Stuart Elborn, Barbara C. Kahl, Olivier Denis, Patrick Plésiat, Hamidou Traore, Paul M. Tulkens, Francis Vanderbist & Françoise Van Bambeke. (2017) Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients . European Respiratory Journal 49:5, pages 1601847.
Crossref
Karen Bush & Malcolm G. P. Page. (2017) What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles. Journal of Pharmacokinetics and Pharmacodynamics 44:2, pages 113-132.
Crossref
Yuichiro Shindo & Yoshinori Hasegawa. 2017. Anti-infectives and the Lung. Anti-infectives and the Lung 206 231 .
George G. Zhanel, Erika Hartel, Heather Adam, Sheryl Zelenitsky, Michael A. Zhanel, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Alfred S. Gin, Daryl J. Hoban, Joseph P. LynchIIIIII & James A. Karlowsky. (2016) Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. Drugs 76:18, pages 1737-1757.
Crossref
Mamun-Ur Rashid, Staffan Rosenborg, Georgios Panagiotidis, Johan Holm, Karin Söderberg Löfdal, Andrej Weintraub & Carl Erik Nord. (2016) Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota. Antimicrobial Agents and Chemotherapy 60:7, pages 4244-4251.
Crossref
Jeffrey A. Keelan, Matthew S. Payne, Matthew W. Kemp, Demelza J. Ireland & John P. Newnham. (2016) A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy. Frontiers in Immunology 7.
Crossref
Jesse A. Jones, Kristopher G. Virga, Giuseppe Gumina & Kirk E. Hevener. (2016) Recent advances in the rational design and optimization of antibacterial agents. MedChemComm 7:9, pages 1694-1715.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.